Status:
WITHDRAWN
Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk Factors
Lead Sponsor:
Intermountain Health Care, Inc.
Conditions:
Chronic Hepatitis C Virus Infection
Eligibility:
All Genders
18-75 years
Brief Summary
Although infection with the hepatitis C virus (HCV) can result in acute hepatitis; it more commonly progresses to chronic hepatitis. The acute process is most often asymptomatic. Acute HCV typically l...
Detailed Description
A. SPECIFIC AIMS (limit one page) 1. Compare yield of risk based versus risk based and birth cohort screening for hepatitis C virus as a function of number invited to screen. The control group will r...
Eligibility Criteria
Inclusion
- anyone between the ages of 18 and 75 years old.
Exclusion
- anyone who gives a history of chronic Hepatitis C virus infection or who has had a positive lab result in the past.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01813266
Start Date
May 1 2013
End Date
April 1 2014
Last Update
March 22 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Intermountain Medical Center
Murray, Utah, United States, 84157